Control IgG was a Nicotiana-derived human IgG against toxin A. respectively). The additional plant-derived human mAbs directed against option epitopes displayed neutralizing activity, but conferred less protection in vivo than palivizumab-N or palivizumab. Palivizumab remains one of the most efficacious RSV mAbs described to date. Production in plants may reduce manufacturing costs and improve the […]